Orgenesis Inc. announced that it has entered into a securities purchase agreement to issue 1,410,256 shares at a price of $0.78 per unit and warrants at a price of $1.1 million on November 8, 2023. The warrants will be exercisable immediately following the date of issuance and may be exercised for a period of five years from the initial exercisability date at an exercise price of $0.78 per share. The transaction is expected to close on November 9, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5149 USD | +5.95% | +7.27% | +2.84% |
May. 20 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+2.84% | 17.55M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.93% | 42.5B | |
+16.25% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. announced that it expects to receive $1.1 million in funding